Journal article
Economic impact of primary open-angle glaucoma in Australia
M Dirani, JG Crowston, PS Taylor, PT Moore, S Rogers, ML Pezzullo, JE Keeffe, HR Taylor
Clinical and Experimental Ophthalmology | Published : 2011
Abstract
Background: Glaucoma is the World's leading cause of irreversible blindness, and poses serious public health and economic concerns. Design: Review. Samples: Published randomized trials and population-based studies since 1985. Methods: We report the economic impact of primary open-angle glaucoma and model the effect of changes in detection rates and management strategies. Main Outcome Measures: The cost-effectiveness of different interventions to prevent vision loss from primary open-angle glaucoma was measured in terms of financial cost (Australian dollars) and disability-adjusted life years. Results: The prevalence of glaucoma in Australia is expected to increase from 208000 in 2005 to 3790..
View full abstractGrants
Funding Acknowledgements
Supported by an unrestricted grant from Allergan, Inc.